...
...
Next Story

Who will opt for a vaccine with question marks on its reliability: Manish Tewari

Drug Control General of India (DCGI) on Sunday approved the Oxford University-AstraZeneca Covid-19 vaccine, Covishield, and Bharat Biotech’s Covaxin for restricted emergency use.

Updated on: Jan 5, 2021, 13:24:14 IST
Hindustan Times, New Delhi | By
Prefer HTon Google
Advertisement

Congress leader Manish Tewari on Tuesday alleged the government has “politically misused the Covid-19 pandemic in its entirety” as he also criticised it over the grant of approval to Bharat Biotech International Limited’s vaccine against the coronavirus disease (Covid-19) for restricted use. Tewari, however, did not name the Hyderabad-based company. Several leaders of the Congress have already called the approval to Bharat Biotech’s vaccine “premature” and said that it can prove dangerous.

Manish Tewari accused the government of politically misusing the Covid-19 pandemic. (Sonu Mehta/HT File Photo)
Manish Tewari accused the government of politically misusing the Covid-19 pandemic. (Sonu Mehta/HT File Photo)

“The BJP government has politically misused the Covid-19 pandemic in its entirety. The controversy over the vaccine is its latest manifestation. Who is going to get himself vaccinated with a vaccine that has question marks on its reliability,” Tewari was quoted as saying by new agency ANI.

Follow latest updates on Covid-19 here

“The BJP government has done a great disservice to that company which must have invested crores of rupees in research and development. In their quest to prove their ‘Atmanirbhar Bharat’ they have licensed a vaccine whose phase III trials are not complete,” Tewari also said, according to ANI.

Drug Control General of India (DCGI) on Sunday approved the Oxford University-AstraZeneca Covid-19 vaccine, Covishield, and Bharat Biotech’s Covaxin for restricted emergency use.

Amid the political slugfest between the opposition and ruling party leaders, Bharat Biotech chairperson and managing director, Krishna Ella, on Monday hit out at comments suggesting that Covaxin, was “safe like water”, and said that their Phase 3 efficacy data, likely to be out by February or March, will silence all critics.

The company also asked for a weeks’ time to prove with evidence that its vaccine also worked against the new UK variant of Sars-Cov-2 virus as 90% of the vaccines targeted just the spike protein of the virus but Covaxin was an inactivated whole virion vaccine.

 
Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather and major national developments.
Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather and major national developments.
SHARE THIS ARTICLE ON
Hindustantimes wants to start sending you push notifications. Click allow to subscribe